Atara Biotherapeutics Inc (ATRA)
14.38
+2.71
(+23.22%)
USD |
NASDAQ |
Nov 13, 16:00
14.33
-0.05
(-0.35%)
After-Hours: 20:00
Atara Biotherapeutics Max Drawdown (5Y): 99.45% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.45% |
| September 30, 2024 | 99.45% |
| August 31, 2024 | 99.45% |
| July 31, 2024 | 99.45% |
| June 30, 2024 | 99.45% |
| May 31, 2024 | 99.45% |
| April 30, 2024 | 99.45% |
| March 31, 2024 | 99.45% |
| February 29, 2024 | 99.45% |
| January 31, 2024 | 99.45% |
| December 31, 2023 | 99.45% |
| November 30, 2023 | 99.45% |
| October 31, 2023 | 97.01% |
| September 30, 2023 | 96.72% |
| August 31, 2023 | 96.72% |
| July 31, 2023 | 96.55% |
| June 30, 2023 | 96.55% |
| May 31, 2023 | 96.48% |
| April 30, 2023 | 94.97% |
| March 31, 2023 | 94.50% |
| February 28, 2023 | 94.46% |
| January 31, 2023 | 94.46% |
| December 31, 2022 | 94.46% |
| November 30, 2022 | 94.46% |
| October 31, 2022 | 94.46% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.46% |
| August 31, 2022 | 94.46% |
| July 31, 2022 | 94.11% |
| June 30, 2022 | 90.98% |
| May 31, 2022 | 90.98% |
| April 30, 2022 | 90.98% |
| March 31, 2022 | 90.98% |
| February 28, 2022 | 90.98% |
| January 31, 2022 | 90.98% |
| December 31, 2021 | 90.98% |
| November 30, 2021 | 90.98% |
| October 31, 2021 | 90.98% |
| September 30, 2021 | 90.98% |
| August 31, 2021 | 90.98% |
| July 31, 2021 | 90.98% |
| June 30, 2021 | 90.98% |
| May 31, 2021 | 90.98% |
| April 30, 2021 | 90.98% |
| March 31, 2021 | 90.98% |
| February 28, 2021 | 90.98% |
| January 31, 2021 | 90.98% |
| December 31, 2020 | 90.98% |
| November 30, 2020 | 90.98% |
| October 31, 2020 | 90.98% |
| September 30, 2020 | 90.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.99%
Minimum
Nov 2019
99.45%
Maximum
Nov 2023
93.30%
Average
90.98%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -58.32 |
| Beta (5Y) | 0.4955 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 97.46% |
| Historical Sharpe Ratio (5Y) | -0.5328 |
| Historical Sortino (5Y) | -1.004 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.87% |